Documents | Adalimumab for the treatment of adults with psoriasis | Guidance | NICE

Documents

A list of downloadable documents created during development.

Other information

TA146 Adalimumab ar gyfer soriasis: deall canllawiau NICE (fformat MS Word) ^{MSWord 314 KB} 23 March 2009

Background information

Psoriasis - adalimumab: final appraisal determination (FAD)

Psoriasis - adalimumab: final appraisal determination (FAD) information
Psoriasis - adalimumab: final appraisal determination (FAD) ^{PDF 112.28 KB} 25 April 2008
Response to consultee, commentator and public comments on the ACD and comments from website consultation ^{PDF 61.66 KB} 25 April 2008
Consultee and commentator comments on the ACD
Wyeth Pharmaceuticals ^{PDF 152.91 KB} 25 April 2008
Welsh Assembly Government ^{PDF 13.42 KB} 25 April 2008
Royal College of Nursing ^{PDF 20.28 KB} 25 April 2008
Merck Serono ^{PDF 282.95 KB} 25 April 2008
Department of Health ^{PDF 12.67 KB} 25 April 2008
British Association of Dermatologists ^{PDF 13.06 KB} 25 April 2008
Abbott Laboratories ^{PDF 24.7 KB} 25 April 2008

Psoriasis - adlimumab: appraisal consultation

Psoriasis - adlimumab: appraisal consultation information
Psoriasis - adalimumab: appraisal consultation document information
Psoriasis - adalimumab: appraisal consultation - pre-meeting briefing ^{PDF 178.76 KB} 01 February 2008
Psoriasis - adalimumab: appraisal consultation - Evidence Review Group report ^{PDF 447.83 KB} 01 February 2008
Psoriasis - adalimumab: appraisal consultation - Non-manufacturer submissions
British Association of Dermatologists ^{PDF 106.92 KB} 01 February 2008
Psoriasis and Psoriatic Arthritis Alliance ^{PDF 48.14 KB} 01 February 2008
Psoriasis Association ^{PDF 49.4 KB} 01 February 2008
Royal College of Nursing ^{PDF 14.76 KB} 01 February 2008
Royal College of Physicians ^{PDF 42.83 KB} 01 February 2008
Welsh Assembly Government ^{PDF 50.04 KB} 01 February 2008
Psoriasis - adalimumab: appraisal consultation - Manufacturer submission: Abbott Laboratories Ltd ^{PDF 1.24 MB} 01 February 2008
Psoriasis - adalimumab: appraisal consultation - Expert written personal statements
Barker ^{PDF 16.65 KB} 01 February 2008
Chandler ^{PDF 21.95 KB} 01 February 2008
Griffiths ^{PDF 17.54 KB} 01 February 2008
Jobling ^{PDF 16.48 KB} 01 February 2008

Psoriasis - adalimumab: Draft scope - pre-referral

Psoriasis - adalimumab: Draft scope - pre-referral ^{PDF 32.23 KB} 07 September 2007

Psoriasis - adalimumab: Provisional matrix of consultees and commentators - pre- referral

Psoriasis - adalimumab: Provisional matrix of consultees and commentators - pre- referral ^{PDF 38.95 KB} 07 September 2007

Psoriasis - adalimumab: Response to comments on the draft scope

Psoriasis - adalimumab: Response to comments on the draft scope ^{PDF 126.01 KB} 06 August 2007